<h3>SMIT 2017 Conference</h3><p>Torino (Italy) 09-10 November 2017</p><h3>SMIT 2017 Conference</h3><p>Torino (Italy) 09-10 November 2017</p><h3>SMIT 2017 Conference</h3><p>Torino (Italy) 09-10 November 2017</p><h3>SMIT 2017 Conference</h3><p>Torino (Italy) 09-10 November 2017</p><h3>SMIT 2017 Conference</h3><p>Torino (Italy) 09-10 November 2017</p><h3>SMIT 2017 Conference</h3><p>Torino (Italy) 09-10 November 2017</p><h3>SMIT 2017 Conference</h3><p>Torino (Italy) 09-10 November 2017</p><h3>SMIT 2017 Conference</h3><p>Torino (Italy) 09-10 November 2017</p><h3>SMIT 2017 Conference</h3><p>Torino (Italy) 09-10 November 2017</p><h3>SMIT 2017 Conference</h3><p>Torino (Italy) 09-10 November 2017</p>
< associate and block membership - improved conditions
09.01.2017 17:05 Age: 253 days

Letter from our SMIT President Alberto Arezzo


Dear SMIT members,

at the beginning of my annual term as SMIT President I would like to share with you my enthusiasm, my pride and my willingness to dedicate all my efforts to strengthen the Society and to increase its international prestige. To succeed to a long series of prestigious innovators in medicine represents for me a stimulus and a challenge. SMIT has a glorious history, a solid present and I am sure will have a brilliant future.

The recent Delft Congress was a huge success in terms of scientific quality, social program and attendance. I would like to thank Jenny Dankelman and John van den Dobbelsteen and all the members of the board for this excellent result. But the Delft success is already part of the SMIT history.

At present, we are all concentrated on the organization of the next SMIT Congress, the 29th SMIT Congress that will take place in Torino, on November 7-9th 2017. After Rome 2004, Naples 2005 it is the 3rd time that SMIT will have the honour and the burden to organize the most important meeting on Medical Innovation and Technology in the world. I hope Torino, with his very long tradition of R&D oriented to the industry, will keep the expectations.

iSMIT has a long and prestigious tradition, but navigated in calm and troubled water along the decades. We cannot say it is a strong Society, it does not have a solid financial situation, but it represents the higher scientific standard in medical innovation and technology. Nevertheless, the unique success of minimally invasive therapies and their diffusion and spread in every country and in every field of medical interest, represent a danger for our future. The different Societies devoted to specific organs (colorectal, upper GI, HPB) or to specific pathologies (bariatric, parietal surgery, oncology) have all embraced innovation and technology and their activities are nowadays largely focused on minimally invasive therapy. Therefore. We will have to work hard to maintain our leadership.

 

The program of my presidency will be centred on 3 actions:

1.        Increasing the daily activity of the Society and the communication between the board and the members. SMIT organizes every year in fall a great scientific event, but during the rest of the year we have a limited contact with our members. The first action will be to continue the improvement of all the activities of our web site. I’ll do my best to sustain this action and to stimulate our members to play an active role. At the same time we will increase the frequency of our newsletters: at least every three months a formal newsletter will be mailed to all the members regarding ongoing activities of the members. This should allow to exchange info and to be a bidirectional activity:  I invite all of you to send us any news, any info that you would like to share with the other members.

2.        Invest in Research and Education by participating to EU calls as well as in the US and in Asia, under the umbrella of SMIT, providing a task force of experts to participate to the R&D or the clinical advisor activity of such projects. For this already before Torino, and even more directly in Torino, I will organise with the help of volunteers of the SC, virtual working tables to investigate potential new achievements in different clinical fields. This brainstorming activity should be directed by senior members with experience but should involve possibly young generations, in the perspective to produce proposals of research projects to apply for funding in the different opportunities.

3.        Establishing strong relationships with organ related Societies in order to reinforce the role of SMIT as the leader in the field of minimally invasive therapy and technology: we should be the reference for these different societies for new techniques and technologies while we will cooperate with them in defining the clinical role of such techniques and technologies

 

Last but not least, it is for me a great pleasure to have the opportunity to work in the next year with a group of true friends: all the members of Steering Committee are not only successful clinicians, engineers and researchers, but great friends. We promise you to dedicate all our efforts to the success of our Society. But we need your help. SMIT is YOUR Society: you should feel it, you should work with us. You should not ask what SMIT can do for your, but what you can do for SMIT.

 

 Alberto Arezzo, SMIT President